NIH-funded research R21 grant

Understanding how mutations in the CLPB gene affect blood cell development

Official title: Mechanistic links between mutations in the CLPB gene and congenital neutropenia

Funded at Kansas State University · NIH-10630259 · Data updated 2026-11-12

This study is looking at how changes in the CLPB gene can cause congenital neutropenia, a condition that makes it hard for your body to make white blood cells, which are important for fighting infections, and the researchers hope to find ways to help people with this condition feel better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startJune 1, 2022
Project endMay 31, 2026
Funding year2023
Award (this year)$191,406
NIH project number5R21AI166525-02
Project IDNIH-10630259 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with congenital neutropenia, particularly those with known mutations in the CLPB gene.

Less likely to help

Patients without congenital neutropenia or those whose condition is not linked to mutations in the CLPB gene may not benefit from this research.

What this research studies

This research investigates the role of the CLPB gene in congenital neutropenia, a serious condition that affects the body's ability to produce white blood cells. The researchers will explore how mutations in this gene disrupt normal cell function and lead to severe health issues, including life-threatening infections. By using cell line models, they aim to understand the molecular mechanisms involved in neutrophil differentiation and how these processes are altered by genetic mutations. This could provide insights into potential therapeutic approaches for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with congenital neutropenia.

How similar studies have gone: While the specific approach of this research is novel, similar studies have shown promise in understanding genetic causes of blood disorders.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Zolkiewska, Anna — Kansas State University
  • Study coordinator: Zolkiewska, Anna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.